Skip to main content
padlock icon - secure page this page is secure

Medically refractory neurosarcoidosis treated with infliximab

Buy Article:

$52.00 + tax (Refund Policy)


Neurosarcoidosis can worsen despite standard immunosuppressive therapy, a situation for which there is no established medical management. We present three cases of medically refractory neurosarcoidosis treated with infliximab. All three patients showed a clinical response to this treatment and side effects were limited. A summary of reported cases of neurosarcoidosis treated with infliximab is included. This case series supports a role for infliximab in the treatment of patients with medically refractory neurosarcoidosis.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: anti-inflammatory agent; factor-alpha; infliximab; monoclonal antibody; sarcoidosis; tumour necrosis

Document Type: Research Article

Affiliations: 1: Department of Neurology, Auckland City Hospital, Auckland 2: Department of Neurology, Christchurch Hospital, Christchurch, New Zealand

Publication date: April 1, 2011

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more